Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage

DNA Repair

Volumn 10, Issue 5, 2011, Pages 518-525

  Castillo, Pau ^a   Bogliolo, Massimo ^a,b   Surralles, Jordi ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

ATM; DNA repair; Fanconi anemia; Oxidative damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ATM PROTEIN; BIOLOGICAL MARKER; FANCONI ANEMIA GROUP D2 PROTEIN; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; SERINE; URACIL DERIVATIVE;

ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; FANCONI ANEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IONIZING RADIATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

ANIMALS; ATAXIA TELANGIECTASIA; BROMATES; CELL CYCLE PROTEINS; CELL LINE; DEOXYGUANOSINE; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HISTONES; HUMANS; HYDROGEN PEROXIDE; MICE; OXIDANTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; S PHASE; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

ATAXIA TELANGIECTASIA;

EID: 79955096891     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.02.007     Document Type: Article

References (51)

1. Callen E., Casado J.A., Tischkowitz M.D., Bueren J.A., Creus A., Marcos R., Dasi A., Estella J.M., Munoz A., Ortega J.J., de Winter J., Joenje H., Schindler D., Hanenberg H., Hodgson S.V., Mathew C.G., Surralles J. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 2005, 105:1946-1949.
2. Kutler D.I., Singh B., Satagopan J., Batish S.D., Berwick M., Giampietro P.F., Hanenberg H., Auerbach A.D. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003, 101:1249-1256.
3. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 2007, 8:735-748.
4. Meindl A., Hellebrand H., Wiek C., Erven V., Wappenschmidt B., Niederacher D., Freund M., Lichtner P., Hartmann L., Schaal H., Ramser J., Honisch E., Kubisch C., Wichmann H.E., Kast K., Deissler H., Engel C., Muller-Myhsok B., Neveling K., Kiechle M., Mathew C.G., Schindler D., Schmutzler R.K., Hanenberg H. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 2010, 42:410-414.
5. Vaz F., Hanenberg H., Schuster B., Barker K., Wiek C., Erven V., Neveling K., Endt D., Kesterton I., Autore F., Fraternali F., Freund M., Hartmann L., Grimwade D., Roberts R.G., Schaal H., Mohammed S., Rahman N., Schindler D., Mathew C.G. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 2010, 42:406-409.
6. Singh T.R., Bakker S.T., Agarwal S., Jansen M., Grassman E., Godthelp B.C., Ali A.M., Du C.H., Rooimans M.A., Fan Q., Wahengbam K., Steltenpool J., Andreassen P.R., Williams D.A., Joenje H., de Winter J.P., Meetei A.R. Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood 2009, 114:174-180.
7. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 2001, 7:249-262.
8. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007, 129:289-301.
9. Meetei A.R, de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 2003, 35:165-170.
10. Longerich S., San Filippo J., Liu D., Sung P. FANCI binds branched DNA and is mono-ubiquitinated by UBE2T-FANCL. J. Biol. Chem. 2009.
11. Castillo V., Cabre O., Marcos R., Surralles J. Molecular cloning of the Drosophila Fanconi anaemia gene FANCD2 cDNA. DNA Repair (Amst) 2003, 2:751-758.
12. Marek L.R., Bale A.E. Drosophila homologs of FANCD2 and FANCL function in DNA repair. DNA Repair (Amst) 2006, 5:1317-1326.
13. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., D'Andrea A.D. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002, 109:459-472.
14. Andreassen P.R., D'Andrea A.D., Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 2004, 18:1958-1963.
15. Pichierri P., Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. Embo J. 2004, 23:1178-1187.
16. Jacquemont C., Taniguchi T. The Fanconi anemia pathway and ubiquitin. BMC Biochem. 2007, 1(Suppl. 8):S10.
17. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 2004, 13:1241-1248.
18. Bogliolo M., Lyakhovich A., Callen E., Castella M., Cappelli E., Ramirez M.J., Creus A., Marcos R., Kalb R., Neveling K., Schindler D., Surralles J. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. Embo J. 2007, 26:1340-1351.
19. Wilson J.B., Yamamoto K., Marriott A.S., Hussain S., Sung P., Hoatlin M.E., Mathew C.G., Takata M., Thompson L.H., Kupfer G.M., Jones N.J. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene 2008, 27:3641-3652.
20. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002, 100:2414-2420.
21. D'Andrea A.D, Grompe M. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 2003, 3:23-34.
22. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1110-1115.
23. Houghtaling S., Newell A., Akkari Y., Taniguchi T., Olson S., Grompe M. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Hum. Mol. Genet. 2005, 14:3027-3033.
24. Clarke A.A., Philpott N.J., Gordon-Smith E.C., Rutherford T.R. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br. J. Haematol. 1997, 96:240-247.
25. von Sonntag C. The Chemical Basis of Radiation Biology 1987, Taylor and Francis, London.
26. Pagano G., Degan P., d'Ischia M., Kelly F.J., Nobili B., Pallardo F.V., Youssoufian H., Zatterale A. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur. J. Haematol. 2005, 75:93-100.
27. Joenje H., Oostra A.B. Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia. Hum. Genet. 1983, 65:99-101.
28. D'Errico M., Parlanti E., Dogliotti E. Mechanism of oxidative DNA damage repair and relevance to human pathology. Mutat. Res. 2008, 659:4-14.
29. Zhang Q.S., Eaton L., Snyder E.R., Houghtaling S., Mitchell J.B., Finegold M., Van Waes C., Grompe M. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res. 2008, 68:1601-1608.
30. Pagano G., Korkina L.G., Degan P., Del Principe D., Lindau-Shepard B., Zatterale A., Franceschi C. In vitro hypersensitivity to oxygen of Fanconi anemia (FA) cells is linked to ex vivo evidence for oxidative stress in FA homozygotes and heterozygotes. Blood 1997, 89:1111-1112.
31. Degan P., Bonassi S., De Caterina M., Korkina L.G., Pinto L., Scopacasa F., Zatterale A., Calzone R., Pagano G. In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995, 16:735-741.
32. Mace-Aime G., Couve S., Khassenov B., Rosselli F., Saparbaev M.K. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks. Environ. Mol. Mutagen. 2010, 51:508-519.
33. Hazra T.K., Izumi T., Boldogh I., Imhoff B., Kow Y.W., Jaruga P., Dizdaroglu M., Mitra S. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3523-3528.
34. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002, 1:3-25.
35. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9915-9919.
36. Chou W.C., Wang H.C., Wong F.H., Ding S.L., Wu P.E., Shieh S.Y., Shen C.Y. Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. Embo J. 2008, 27:3140-3150.
37. Ballmaier D., Epe B. DNA damage by bromate: mechanism and consequences. Toxicology 2006, 221:166-171.
38. Kawanishi S., Murata M. Mechanism of DNA damage induced by bromate differs from general types of oxidative stress. Toxicology 2006, 221:172-178.
39. Callen E., Samper E., Ramirez M.J., Creus A., Marcos R., Ortega J.J., Olive T., Badell I., Blasco M.A., Surralles J. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum. Mol. Genet. 2002, 11:439-444.
40. Frosina G., Fortini P., Rossi O., Carrozzino F., Raspaglio G., Cox L.S., Lane D.P., Abbondandolo A., Dogliotti E. Two pathways for base excision repair in mammalian cells. J. Biol. Chem. 1996, 271:9573-9578.
41. Cappelli E., Degan P., Frosina G. Comparative repair of the endogenous lesions 8-oxo-7, 8-dihydroguanine (8-oxoG), uracil and abasic site by mammalian cell extracts: 8-oxoG is poorly repaired by human cell extracts. Carcinogenesis 2000, 21:1135-1141.
42. Tanaka M., Lai J.S., Herr W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 1992, 68:755-767.
43. Bogliolo M., Taylor R.M., Caldecott K.W., Frosina G. Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells. Oncogene 2000, 19:5781-5787.
44. Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., Livingston D.M. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell. 2006, 22:719-729.
45. Hsu G.W., Ober M., Carell T., Beese L.S. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature 2004, 431:217-221.
46. Cappelli E., Rossi O., Chessa L., Frosina G. Efficient DNA base excision repair in ataxia telangiectasia cells. Eur. J. Biochem. 2000, 267:6883-6887.
47. Imlay J.A., Chin S.M., Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988, 240:640-642.
48. Saito H., Hammond A.T., Moses R.E. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat. Res. 1993, 294:255-262.
49. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., Wilson S.H. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 1996, 379:183-186.
50. Cappelli E., Taylor R., Cevasco M., Abbondandolo A., Caldecott K., Frosina G. Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J. Biol. Chem. 1997, 272:23970-23975.
51. Lyakhovich A., Surralles J. New roads to FA/BRCA pathway: H2AX. Cell Cycle 2007, 6:1019-1023.